>
pdufa.bio

Nalbuphine ER

Updated ยทnext FDA decision on the calendar

Nalbuphine ER is a Trevi Therapeutics, Inc. program. Every date links its source.

TRVI catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Trevi Therapeutics, Inc. (TRVI). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026TRVI

Questions

When is Nalbuphine ER's next FDA decision or readout?

No upcoming catalyst is on our calendar for Nalbuphine ER; no FDA decisions are on record below.

What happened at Nalbuphine ER's most recent FDA decision?

No FDA decision for Nalbuphine ER is in our archive yet.

Who makes Nalbuphine ER?

Trevi Therapeutics, Inc. (TRVI).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.